Navigation Links
New Study Links Air Pollution to Alzheimer’s Disease -- Says Cure Alzheimer's Fund
Date:4/15/2013

Boston, Massachusetts (PRWEB) April 15, 2013

High levels of exposure to air pollution may increase the risk of Alzheimer’s disease, according to a new study completed with a grant from the Cure Alzheimer’s Fund.

The study, led by Cure Alzheimer’s Research Consortium member Sam Gandy, M.D., Ph.D., of the Icahn School of Medicine at Mount Sinai, examined how elements in air pollution such as nickel nanoparticles affect the levels of certain peptides in the brain that are found to be at heightened levels in patients suffering from Alzheimer’s Disease.

“We don’t yet completely understand why the peptides accumulate, but we do know the genes responding to the peptides play an important role in developing Alzheimer’s,” said Gandy.

To test the correlation, mice were examined 24 hours after being exposed to air pollution where they showed a 72-129 percent increase in levels of the peptides.

“We were startled when three hours of air pollution exposure for the mice showed such a rapid and dramatic elevation,” said Gandy.

While the study links air pollution to Alzheimer’s, Gandy emphasized that more research is needed to better understand the role of genetics saying, “There is probably some interaction between genetic susceptibility to air pollution that mitigates the response to the exposure.”

Additionally, the study emphasized the need to better understand air pollution’s effects on humans in a natural setting.

“We suspect that humans will have an even more dramatic reaction to air pollution than mice because the human molecule is far stickier, making it highly prone to clumping and accumulation,” said Gandy. This could mean an even stronger link between air pollution and Alzheimer’s than is reflected in the study’s findings.

Interest in linking air pollution exposure to Alzheimer’s disease started when studies showed young people living in highly polluted cities to have Alzheimer Disease pathology, and because of existing evidence linking air pollution to insulin resistance and Type 2 Diabetes.

“We wanted to see if we could better explain why so many people were showing signs of Alzheimer’s at such a young age,” Gandy said. “The results of this study clearly show an urgent need to better understand this link.”

In just seven years, with just $20 million spent, Cure Alzheimer’s Fund has an unparalleled track record. Its Alzheimer’s Genome Project (AGP) TM was the largest single disease scan of all time and was considered one of the “Top 10 Medical Breakthroughs in the world in 2008” by Time and CNN. Its funded research work has also been noted by The Wall Street Journal, NPR and the White House.

Read the published paper here.

Read a recent publication from the Archives/Annals of Internal Medicine linking air pollution to cognition here.

Read the full story at http://www.prweb.com/releases/2013/4/prweb10629377.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Study Questions Value of PSA Test for Older Men
2. Doctors Insight Into Patients Lives May Boost Care, Study Finds
3. Drug could improve working memory of people with autism, study finds
4. Freezing Treatment May Help Destroy Lung Tumors: Study
5. Age of Autism Diagnosis May Depend on Symptoms: Study
6. Laser Liposuction May Zap Fat Without Skin Sag: Study
7. In sex, happiness hinges on keeping up with the Joneses, CU-Boulder study finds
8. Vitamin D may reduce risk of uterine fibroids, according to NIH study
9. Groundbreaking study to transform service users involvement in mental health care
10. Zocor Side Effects Update: Bernstein Liebhard LLP Comments on New Study Linking Kidney Problems to High Doses of Zocor, Other Statins
11. Mirena Lawsuits Move Forward, as Bernstein Liebhard LLP Comments on New Mirena IUD Side Effects Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... July 21, 2017 , ... ... students improve their chances of acceptance to a residency in a United States ... earned degrees outside the U.S. , According to data released by the ECFMG®, ...
(Date:7/21/2017)... ... July 21, 2017 , ... West Dermatology is pleased ... Vu, PA-C. Beginning July 17, 2017, Ms. Vu will join West Dermatology’s large network ... experience in dermatology, skin cancer , and more. She graduated from the University ...
(Date:7/21/2017)... ... July 21, 2017 , ... How physicians and ... the rise, say researchers presenting their work at the American Orthopaedic Society ... combination of evaluating the patterns of change in concussion symptom presentation, diagnostic tools ...
(Date:7/20/2017)... ... July 20, 2017 , ... Acute myeloid leukemia (AML) is ... rapidly without treatment. Newly diagnosed patients face intense chemotherapy regimens and a stem ... With such a challenging diagnosis that requires immediate action, patients and caregivers ...
(Date:7/20/2017)... ... ... For individuals with extended hospital stays or who are residents of nursing ... specially designed to accommodate patients with a wide range of ailments or special needs, ... has invented the patent-pending PORTABLE ARM REST, a specially designed armrest that features many ...
Breaking Medicine News(10 mins):
(Date:7/12/2017)... and Company (NYSE: LLY ) has entered into ... litigation in the U.S. District Court for the Eastern District ... (tadalafil) unit dose patent. This patent was previously set ... agreement, Cialis exclusivity is now expected to end at the ... patent for Cialis is valid and infringed by companies seeking ...
(Date:7/11/2017)... 11, 2017  The global market for liquid biopsy ... $394.1 million in 2016.  Although in early stages, the ... in particular as a result of the gradual shift ... recent introduction of a significant number of new liquid ... of tumor biomarkers to guide treatment decisions. ...
(Date:7/11/2017)... July 11, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral drug ... Drug Administration (FDA) has agreed to schedule an End-of-Phase ... IIb trial of its oral insulin capsule ORMD-0801 in ... trial met primary and secondary endpoints by indicating a ...
Breaking Medicine Technology: